human immunoglobulin (intramuscular, measles/hepatitis virus infection), Hebei Da'an Pharmaceutical

人免疫球蛋白(河北大安制药)

Report date: 2022/01/14 13:23:58

Base Information

Drug Namehuman immunoglobulin (intramuscular, measles/hepatitis virus infection), Hebei Da'an Pharmaceutical
Drug Alias NameN/A
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitisMeasles
Global Approved IndicationsHepatitisMeasles
Approved Indications in ChinaHepatitisMeasles
Original Approved Country/TerritoryMainland China
Original Approved Date2006/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHepatitisMeasles
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A